4.7 Letter

A CD14 Polymorphism (C-159T rs2569190) Is Associated With SARS-CoV-2 Infection and Mortality in the European Population

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

Levels of Soluble CD14 and Tumor Necrosis Factor Receptors 1 and 2 May Be Predictive of Death in Severe Coronavirus Disease 2019

Emily R. Bowman et al.

Summary: Levels of TNFR1 and TNFR2 in COVID-19 patients are associated with disease severity, and patients with lower levels of TNFR1 and TNFR2 are more likely to recover.

JOURNAL OF INFECTIOUS DISEASES (2021)

Article Rheumatology

CD14 (C-159T) polymorphism is associated with increased susceptibility to SLE, and plasma levels of soluble CD14 is a novel biomarker of disease activity: A hospital-based case-control study

Aditya K. Panda et al.

Summary: The CD14 (C-159T) polymorphism is associated with an increased predisposition to the development of SLE and lupus nephritis, and sCD14 is a promising novel biomarker for assessing disease activity and lupus nephritis.
Article Immunology

THE ROLE OF TLR4 AND CD14 POLYMORPHISMS IN THE PATHOGENESIS OF RESPIRATORY SYNCYTIAL VIRUS BRONCHIOLITIS IN GREEK INFANTS

M. Goutaki et al.

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2014)

Article Infectious Diseases

Contribution of CD14-159C/T polymorphism to tuberculosis susceptibility: a meta-analysis

J. Zhao et al.

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2013)